📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Assessment of selected media supplements to improve F/HN lentiviral vector production yields. (2017)

First Author: Gélinas JF

Attributed to: Development of a novel, potent, safe, long-lasting lentivirus-based gene therapy for cystic fibrosis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41598-017-07893-3

PubMed Identifier: 28860488

Publication URI: http://europepmc.org/abstract/MED/28860488

Type: Journal Article/Review

Volume: 7

Parent Publication: Scientific reports

Issue: 1

ISSN: 2045-2322